Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isovue and Visipaque in renally impaired patients undergoing CT
NCT00292487Phase 4Completed
- Sponsor
- Bracco Diagnostics Inc.
- Start
- Nov 2004
- Primary completion
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in contrast-induced nephropathy (CIN) comparing Iopamidol Arm with Iodixanol Arm (2 arms). Primary endpoint: Contrast-induced nephropathy. Started Nov 2004; status: completed.
02
Drugs
iopamidoliodixanol
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT00292487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00292487.